Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
115.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.40 (1.203%)
Market Cap: £206.21m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

New Reporting Structure

26 Jun 2024 14:00

RNS Number : 0095U
TT Electronics PLC
26 June 2024
 

 

26 June 2024

 

TT Electronics plc

 

New Reporting Structure

 

 

TT Electronics plc ("TT", "the Group"), a global engineer and manufacturer of electronic solutions for critical applications, today publishes historical financial information for 2023, including the half year splits, reflecting the new, three region structure.

 

As part of the Capital Market Event on 9 April we articulated the move to a function-led, regional reporting structure. This move from our previous divisional structure will enable us to better leverage our strong engineering and manufacturing capabilities to improve execution, unlock value and improve returns. 

 

The regional reporting structure will be used with effect from the forthcoming interim 2024 results, to be announced on 8 August. For purposes of transparency, supplementary disclosure covering the previous divisional segment performance will be provided at both the interim 2024 results and for the full year 2024 results in early March 2025. There will be no further divisional disclosure beyond this point.

 

The historical financial information contained in the following tables is unaudited.

 

 

Revenue £m

H1 2023

H2 2023

FY 2023

Europe

81.5

88.1

169.6

North America

115.4

114.1

229.5

Asia

112.2

102.6

214.8

Group revenue

309.1

304.8

613.9

 

 

 

Operating profit £m

H1 2023

H2 2023

FY 2023

Europe

4.3

7.6

11.9

North America

13.1

12.0

25.1

Asia

12.1

11.8

23.9

Central costs

(3.9)

(4.2)

(8.1)

Operating profit

25.6

27.2

52.8

 

 

Regional performance in FY23

 

Within the 2023 performance Project Albert accounted for £51.4 million of revenue in Europe and £17.2 million in Asia. By regional operating profit, the three business units disposed accounted for £0.2 million in Europe and £1.7 million in Asia respectively.

 

Pass through revenue is all within the Asia region and was circa £12.6 million in H1 and circa £19.9 million in the full year 2023.

 

 

EUROPE

 

H1 2023

H2 2023

FY 2023

Revenue

81.5

88.1

169.6

Adjusted operating profit1

4.3

7.6

11.9

Adjusted operating margin1

5.3%

8.6%

7.0%

 

NORTH AMERICA

 

H1 2023

H2 2023

FY 2023

Revenue

115.4

114.1

229.5

Adjusted operating profit1

13.1

12.0

25.1

Adjusted operating margin1

11.4%

10.5%

10.9%

 

ASIA

 

H1 2023

H2 2023

FY 2023

Revenue

112.2

102.6

214.8

Adjusted operating profit1

12.1

11.8

23.9

Adjusted operating margin1

10.8%

11.5%

11.1%

 

 

2023 END MARKET EXPOSURE

%

Europe

North America

Asia

Healthcare

3.8

16.7

47.2

Aerospace & Defence

41.6

21.1

2.1

Automation & Electrification

33.3

26.4

48.6

Distribution channel

21.3

35.8

2.1

Total

100

100

100

 

 

 

 

 

 

 

For further information please contact:

 

 

TT Electronics plc

Tel: +44 (0)1932 827 779

Peter France, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Kate Moy, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Ollie Hoare

 

 

 

 

Notes:

 

1. Definitions of Adjusted operating profit and Adjusted operating margin can be found on page 174 of our 2023 Annual Report and Accounts

2. TT will announce its half year results on 8 August 2024.

3. Latest company compiled view of market expectations shows a consensus adjusted profit before tax of £46.2 million within a range of £45.0 million to £47.3 million for the year ended December 2024.

 

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers primarily in the healthcare, aerospace & defence and automation & electrification sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities in the UK, North America and Asia.

Cautionary statement

This update contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this update. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNVURSUUNUAR
Date   Source Headline
28th Apr 20226:05 pmRNSDirector/PDMR Shareholding
27th Apr 20225:20 pmRNSDirector/PDMR Shareholding
27th Apr 202211:22 amRNSHolding(s) in Company
6th Apr 20224:15 pmRNSAnnual Financial Report
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 202211:29 amRNSDirector Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSFull Year Results
1st Mar 20223:35 pmRNSTotal Voting Rights
2nd Feb 20224:30 pmRNSHolding(s) in Company
1st Feb 20223:05 pmRNSTotal Voting Rights
10th Jan 20227:00 amRNSAcquisition of Ferranti Power & Control business
4th Jan 20222:20 pmRNSTotal Voting Rights
22nd Dec 202110:07 amRNSHolding(s) in Company
15th Dec 20214:00 pmRNSHolding(s) in Company
1st Dec 20213:06 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
1st Nov 20215:05 pmRNSBlock Listing Six Monthly Return
1st Nov 20214:56 pmRNSDirector/PDMR Shareholding
30th Sep 20219:40 amRNSDirector/PDMR Shareholding
1st Sep 20211:30 pmRNSTotal Voting Rights
5th Aug 20217:00 amRNSHalf-year Results
2nd Aug 20213:38 pmRNSTotal Voting Rights
2nd Jul 20215:10 pmRNSTotal Voting Rights
16th Jun 20211:32 pmRNSUpdate on 2021 LTIP Award Targets
14th Jun 202110:16 amRNSHolding(s) in Company
1st Jun 20218:11 amRNSTotal Voting Rights
13th May 20211:19 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update
12th May 20214:39 pmRNSDirector/PDMR Shareholding
4th May 20213:00 pmRNSBlock listing Interim Review
4th May 202110:42 amRNSTotal Voting Rights
1st Apr 20214:22 pmRNSTotal Voting Rights
1st Apr 202111:23 amRNSAnnual Report and AGM Arrangements
29th Mar 20218:05 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSVirolens® registration received in Great Britain
25th Mar 202112:11 pmRNSUpdate on Virolens
19th Mar 202112:11 pmRNSDirector/PDMR Shareholding
18th Mar 20213:18 pmRNSHolding(s) in Company
16th Mar 20213:50 pmRNSDirector/PDMR Shareholding
16th Mar 20213:49 pmRNSDirector/PDMR Shareholding
10th Mar 202112:40 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFull Year Results
1st Mar 202112:30 pmRNSTotal Voting Rights
8th Feb 20216:20 pmRNSHolding(s) in Company
1st Feb 202111:36 amRNSTotal Voting Rights
20th Jan 20214:55 pmRNSHolding(s) in Company
19th Jan 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.